Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Overview

The project titled "Development of Novel Drug Delivery Systems for Targeted Cancer Therapy" aims to address the challenges associated with traditional cancer treatments by exploring innovative drug delivery systems. Cancer therapy often involves the use of chemotherapeutic agents that can cause significant side effects due to their non-specific targeting, resulting in damage to healthy tissues. The development of targeted drug delivery systems offers a promising solution by delivering therapeutic agents specifically to cancer cells, thereby minimizing off-target effects and enhancing treatment efficacy. This research focuses on the design and evaluation of novel drug delivery systems tailored for targeted cancer therapy. By utilizing advanced nanotechnology and biomaterials, the project aims to develop drug carriers capable of selectively delivering anti-cancer drugs to tumor sites while sparing healthy tissues. The study will investigate various formulation strategies, including nanoparticle-based drug delivery systems, liposomes, micelles, and other nano-sized carriers, to optimize drug delivery efficiency and therapeutic outcomes. The research overview also emphasizes the importance of understanding the biological mechanisms and tumor microenvironment factors that influence drug delivery and efficacy. By elucidating the interactions between drug carriers and cancer cells, the project aims to enhance the specificity and selectivity of drug delivery systems for improved therapeutic outcomes. Additionally, the study will investigate the potential use of targeting ligands, such as antibodies or peptides, to actively guide drug carriers to cancer cells, further enhancing the precision of treatment delivery. Furthermore, the research overview highlights the significance of preclinical studies and in vitro/vivo evaluations to assess the safety, efficacy, and pharmacokinetics of novel drug delivery systems. By conducting comprehensive experimental analyses and animal studies, the project aims to validate the feasibility and therapeutic potential of the developed drug carriers for targeted cancer therapy. Overall, the project on the "Development of Novel Drug Delivery Systems for Targeted Cancer Therapy" underscores the importance of innovation in drug delivery technologies to revolutionize cancer treatment strategies. Through the integration of interdisciplinary approaches, advanced materials science, and biological insights, this research seeks to pave the way for the development of next-generation drug delivery systems that hold great promise for enhancing the precision, efficacy, and safety of cancer therapy.